The Lescol^® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

By Serruys Patrick WJC   de Feyter Pim J   Benghozi Renée   Hugenholtz Paul G   Lesaffre Emmanuel  

International Journal of Cardiovascular Interventions, Vol. 4, Iss. 4, 2001-12 ,pp. : 165-172

Informa Healthcare

Access to resources Recommend Favorite

Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study

By Haapsamo Mervi   Martikainen Hannu   Tinkanen Helena   Heinonen Seppo   Nuojua-Huttunen Sinikka   Rsnen Juha  

Human Reproduction, Vol. 25, Iss. 12, 2010-12 ,pp. : 2972-2977

Oxford University Press

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study

By Penna I.A.A.  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2396-2401

Oxford University Press

Access to resources Recommend Favorite

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

By Tang Thomas   Glanville Julie   Hayden Catherine J.   White Davinia   Barth Julian H.   Balen Adam H.  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 80-89

Oxford University Press

Access to resources Recommend Favorite